UCLA spin-out Tribogenics landed $2.5 million from a network of angel investors and Flywheel Ventures for the commercialization of its next-generation x-ray technology.
Tribogenics’ technology, developed at UCLA by Carlos Camara, enables low-cost X-ray sources for scientific instruments, security screening and medical devices.
"In a lifetime, a venture capitalist may only see a handful of investments with this amount of economic and human potential, and I couldn’t be more excited to assist the Tribogenics team in realizing that potential," Flywheel Ventures’ Trevor Loy said in prepared remarks.
Newly appointed CEO Dale Fox will lead the commercialization. "Tribogenics technology will enable small mobile X-ray devices that are not possible using existing technology. I’m excited to be leading such an experienced team to bring these solutions to market," Fox said in a statement.
Here’s a roundup of other dealflow and investment news:
SightLine lands strategic investment from ION
The Integrated Oncology Network made an undisclosed investment in radiation, oncology center manager SightLine Health. Read more
HealthTap raises $11.5M in Series A
HealthTap raised $11.5 million in a Series A funding round from Mayfield Fund, Mohr Davidow ventures and Eric Schmidt’s Innovation Endeavors. Read more